% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Lohmann:850813,
      author       = {Lohmann, Philipp and Kocher, M. and Steger, J. and
                      Galldiks, N.},
      title        = {{R}adiomics derived from amino acid {PET} and conventional
                      {MRI} in patients with high-grade gliomas},
      journal      = {The quarterly journal of nuclear medicine and molecular
                      imaging},
      volume       = {62},
      number       = {3},
      issn         = {0392-0208},
      address      = {Torino},
      publisher    = {Ed. Minerva Medica},
      reportid     = {FZJ-2018-04584},
      pages        = {272-80},
      year         = {2018},
      abstract     = {Radiomics is a technique that uses high-throughput
                      computing to extract quantitative features from tomographic
                      medical images such as MRI and PET that usually are beyond
                      visual perception. Importantly, the radiomics approach can
                      be performed using neuroimages that have already been
                      acquired during the routine follow-up of the patients
                      allowing an additional data evaluation at low cost. In
                      Neuro-Oncology, these features can potentially be used for
                      differential diagnosis of newly diagnosed cerebral lesions
                      suggestive for brain tumors or for the prediction of
                      response to a neurooncological treatment option.
                      Furthermore, especially in the light of the recent update of
                      the World Health Organization classification of brain
                      tumors, radiomics also has the potential to non-invasively
                      assess important prognostic and predictive molecular markers
                      such as a mutation in the isocitrate dehydrogenase gene or a
                      1p/19q codeletion which are not accessible by conventional
                      visual interpretation of MRI or PET findings. This review
                      summarizes the current status of the rapidly evolving field
                      of radiomics with a special focus on patients with
                      high-grade gliomas.},
      cin          = {INM-3 / INM-4},
      ddc          = {570},
      cid          = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
      pnm          = {572 - (Dys-)function and Plasticity (POF3-572)},
      pid          = {G:(DE-HGF)POF3-572},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:29869488},
      UT           = {WOS:000445240400006},
      doi          = {10.23736/S1824-4785.18.03095-9},
      url          = {https://juser.fz-juelich.de/record/850813},
}